Use of 5alpha-androstane (alkyl)-3beta,5,6beta-triol in preparation of neuroprotective drugs
AssigneeGuangzhou Cellprotek Pharmaceutical Co., Ltd.
InventorsGuangmei Yan, Haiyan Hu, Tiandong Leng, Hanfei Sang, Jingxia Zhang, Pengxin Qiu, Shujia Zhou, Jiesi Chen, Xiuhua You
Life of this patent
Estimating the term…
Abstract
Disclosed is the use of 5α-androstane(alkyl)-3β,5,6β-triol in preparing neuroprotective drugs. The compound has significant protective effect against neuron injuries caused by cerebral ischemia, spinal cord isehemia or hypoxia and has no obvious toxic reaction within effective dose thereof.
Claims5
1-4. (canceled)
A method for treating a neuron related disease, comprising administering to a subject in need of the treatment a pharmaceutical composition comprising 5α-androstane(alkyl)-3β,5,6β-triol:
The method of claim 1, wherein the neuron related disease is cerebral ischemia.
The method of claim , wherein the neuron related disease is spinal cord ischemic.
The method of claim 1, wherein the neuron related disease is neuron damage caused by hypoxia.
Dependencies are inferred from the claim text.